Abstract
In an era of ongoing need for research to enable evidence-based care for the expanding population with congenital heart disease (CHD), economic fluctuations have impacted research funding. We characterize trends in NIH-funded CHD research from 2005 to 2015. We searched the NIH RePORTER database from 2005 to 2015 using the terms “congenital heart” and “cardiac morphogenesis”. Projects were characterized by year, institute, mechanism, costs, type and topic, and funding trends were analyzed. From 2005 to 2015, NIH funded 633 CHD research projects with total costs of $991 million. The National Heart, Lung, and Blood Institute funded 83% of CHD projects (528, $857 million). The R01 mechanism was used for 45% of projects (288, $421 million). Projects were 70% basic/early translational research, 27% clinical research, and 3% both. Cardiac developmental biology was the most common topic (52%), followed by technology/therapy development (15%), and diagnosis/management (12%). The total number of CHD projects ranged from 153 to 221 per year (30–58 new projects/year), and costs per year ranged from $58 to $116 million. The number of projects and total costs increased until 2012, but decreased again thereafter. CHD research did not experience as much erosion as overall NIH purchasing power; in constant dollars, CHD research funding levels in 2015 were $12 million higher than those in 2005. The NIH supported a diverse portfolio of CHD projects from 2005 to 2015. Support of CHD research projects trended upward until 2012, but declined thereafter due to fiscal austerity measures.
Similar content being viewed by others
Abbreviations
- CHD:
-
Congenital heart disease
- NIH:
-
National Institutes of Health
- RePORT:
-
Research Portfolio Online Reporting Tools
- RePORTER:
-
Research Portfolio Online Reporting Tools Expenditures and Results
- SBIR/STTR:
-
Small business projects
- NHLBI:
-
National Heart, Lung, and Blood Institute
- NICHD:
-
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- PHN:
-
Pediatric Heart Network
- ARRA:
-
American Recovery and Reinvestment Act
- RPG:
-
Research project grants
References
Heron M (2011) Deaths: leading causes for 2007. Natl Vital Stat Rep 59(8):1–95
Global, regional (2015) and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385(9963):117–171
Shuler CO, Black GB, Jerrell JM (2013) Population-based treated prevalence of congenital heart disease in a pediatric cohort. Pediatr Cardiol 34(3):606–611
Mozaffarian D, Benjamin EJ, Go AS et al (2016) Heart Disease and Stroke Statistics-2016 update: a report from the American Heart Association. Circulation 133(4):e38–e360
Mozaffarian D, Benjamin EJ, Go AS et al (2015) Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation 131(4):e29–e322
Karamlou T, Diggs BS, Person T, Ungerleider RM, Welke KF (2008) National practice patterns for management of adult congenital heart disease: operation by pediatric heart surgeons decreases in-hospital death. Circulation 118(23):2345–2352
Dean PN, Hillman DG, McHugh KE, Gutgesell HP (2011) Inpatient costs and charges for surgical treatment of hypoplastic left heart syndrome. Pediatrics 128(5):e1181–e1186
Connor JA, Gauvreau K, Jenkins KJ (2005) Factors associated with increased resource utilization for congenital heart disease. Pediatrics 116(3):689–695
Pasquali SK, He X, Jacobs ML et al (2014) Excess costs associated with complications and prolonged length of stay after congenital heart surgery. Ann Thorac Surg 98(5):1660–1666
Simeone RM, Oster ME, Hobbs CA, Robbins JM, Collins RT, Honein MA (2015) Population-based study of hospital costs for hospitalizations of infants, children, and adults with a congenital heart defect, Arkansas 2006 to 2011. Birth Defects Res A Clin Mol Teratol 103(9):814–820
Gelb BD (2015) History of our understanding of the causes of congenital heart disease. Circ Cardiovasc Genet 8(3):529–536
Collins FA, Rockey S (2013) One nation in support of biomedical research. https://nexus.od.nih.gov/all/2013/09/24/one-nation-in-support-of-biomedical-research/. Accessed 28 Nov 2016
National Institutes of Health (2015) Research Portfolio Online Reporting Tools. http://report.nih.gov/index.aspx. Accessed 23 June 2015
National Institues of Health (2016) NIH grants & funding glossary and acronym list. https://grants.nih.gov/grants/glossary.htm. Accessed 30 Dec 2016
U.S. Bureau of Labor Statistics (2017) Consumer price index inflation calculator. https://www.bls.gov/data/inflation_calculator.htm. Accessed 4 Jan 2017
Gavini N, Hoots WK, Mensah GA, Hanspal M (2015) An analysis of the NIH-supported sickle cell disease research portfolio. Blood Cells Mol Dis 54(2):198–205
Khoury MJ, Clauser SB, Freedman AN et al (2011) Population sciences, translational research, and the opportunities and challenges for genomics to reduce the burden of cancer in the 21st century. Cancer Epidemiol Biomark Prev 20(10):2105–2114
Galis ZS, Thrasher T, Reid DM, Stanley DV, Oh YS (2013) Investing in high blood pressure research: a national institutes of health perspective. Hypertension 61(4):757–761
Bourgeois FT, Murthy S, Pinto C, Olson KL, Ioannids JP, Mandl KD (2012) Pediatric versus adult drug trials for conditions with high pediatric disease burden. Pediatrics 130(2):285–292
Hill KD, Chiswell K, Califf RM, Pearson G, Li JS (2014) Characteristics of pediatric cardiovascular clinical trials registered on ClinicalTrials.gov. Am Heart J 167(6):921–929
Acknowledgements
The authors wish to thank Drs. George Mensah and Bruce Gelb for providing valuable guidance that improved this manuscript.
Funding
No external funding sources were used for this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
There are no conflicts of interest or relationships with industry to disclose. The views expressed are those of the authors and do not necessarily reflect official National Heart, Lung, and Blood Institute positions.
Rights and permissions
About this article
Cite this article
Burns, K.M., Pemberton, V.L., Schramm, C.A. et al. Trends in National Institutes of Health-Funded Congenital Heart Disease Research from 2005 to 2015. Pediatr Cardiol 38, 974–980 (2017). https://doi.org/10.1007/s00246-017-1605-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-017-1605-x